BCL2L11 and neoplasm: Therefore, the author utilized folate-modified liposomes (F-PLP) to deliver a plasmid containing BIM-S (a cell death mediator that interacts with BCL-2) to target lung cancer cells and FRβ-positive macrophages in the tumor microenvironment for the significant suppression of in vivo tumor growth 155.